Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2026 for HLS Therapeutics Inc., €128k.
Filing timeline
BuySaleBrian Thomas Walsh
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Brian Thomas Walsh: trading record in brief
All filings by Brian Thomas Walsh on record concern HLS Therapeutics Inc. Over a trading history stretching from 27 June 2023 to 26 June 2026, the count stands at 5 filings.
No open-market sale appears; the market trades are 2 purchases worth €2,348. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
The record was last updated on 30 June 2026 with a share grant (€128k) in HLS Therapeutics Inc. The clock since the last published purchase (15 November 2023) now reads 1,077 days. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Thomas Walsh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
50,000 shares@ CA$4.140.17% mcap100.0% of flowRestricted Share UnitsTSXSEDI:4741928
Restricted Share UnitsTSXSEDI:4741927
Common SharesTSXSEDI:4209047
200 shares@ CA$2.920.3% of flowCommon SharesTSXSEDI:4209048
Canonical exit: 11 Feb 2024 (T+90)
1,000 shares@ CA$2.911.5% of flowCommon SharesTSXSEDI:4209049
Canonical exit: 13 Feb 2024 (T+90)
5 of 5 declarations
